WS Data Solutions
Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Pyxis Oncology, Inc. Common Stock (PYXS)
Pharmaceutical Preparations
Pyxis Oncology Inc is a clinical-stage oncology company focused on developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve the quality of life for patients. It develops the product candidates to directly kill tumor cells and address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Its lead ADC product candidate is PYX-201, an investigational human IgG1 isotype site-specifically conjugated with an auristatin toxin targeting EDB that initially develop for solid tumors, including NSCLC, hormone receptor-positive breast, ovarian and thyroid cancer. The IO product candidate is PYX-106, designed to block Siglec-15-mediated suppression of T-cell proliferation and function.
321 HARRISON AVENUE
BOSTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
10/08/2021
Market Cap
206,109,659
Shares Outstanding
44,320,000
Weighted SO
44,323,046
Total Employees
N/A
Upcoming Earnings
08/09/2024
Beta
1.2920
Last Div
0.0000
Range
1.35-6.85
Chg
0.0700
Avg Vol
599401
Mkt Cap
206109659
Exch
NASDAQ
Country
US
Phone
617 221 9059
DCF Diff
3.6855
DCF
-0.2555
Div Yield
0.0000
P/S
10.5341
EV Multiple
-3.0234
P/FV
1.2470
Div Yield %
0.0000
P/E
-3.5764
PEG
-0.0742
Payout
0.0000
Current Ratio
9.5306
Quick Ratio
9.5306
Cash Ratio
1.5710
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
552.1433
CCC
-552.1433
Gross Margin
0.8152
Op Margin
-3.5142
Pretax Margin
-3.0258
Net Margin
-3.0258
Eff Tax Rate
-0.0750
ROA
-0.2841
ROE
-0.3834
ROCE
-0.3591
NI/EBT
1.0000
EBT/EBIT
0.8610
EBIT/Rev
-3.5142
Debt Ratio
0.1002
D/E
0.1229
LT Debt/Cap
0.1032
Total Debt/Cap
0.1095
Int Coverage
-40.1859
CF/Debt
-2.7066
Equity Multi
1.2273
Rec Turnover
0.0000
Pay Turnover
0.6611
Inv Turnover
0.0000
FA Turnover
0.8264
Asset Turnover
0.0939
OCF/Share
-0.9338
FCF/Share
-0.9387
Cash/Share
2.5985
OCF/Sales
-2.8873
FCF/OCF
1.0053
CF Coverage
-2.7066
ST Coverage
-42.2212
CapEx Coverage
-189.5705
Div&CapEx Cov
-189.5705
P/BV
1.2470
P/B
1.2470
P/S
10.5341
P/E
-3.5764
P/FCF
-3.6293
P/OCF
-3.7481
P/CF
-3.7481
PEG
-0.0742
P/S
10.5341
EV Multiple
-3.0234
P/FV
1.2470
DPS
0.0000